Results of the votes of the Combined Shareholders’ General Meeting of January 25, 2023
Daix (France), Long Island City (New York, United States), January 26, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with unmet medical need, today announced the results of the votes of its Combined Shareholders’ General Meeting.
The Combined Shareholders' Meeting was held on January 25, 2023 at 2 p.m. at Hôtel Oceania Le Jura, 14 avenue Foch, 21000 Dijon (France), under the chairmanship of Mr. Frédéric Cren, Chairman and Chief Executive Officer and cofounder of Inventiva.
Mr. Frederic Cren proceeded to the usual formalities of the opening of the meeting, in particular to the constitution of the Bureau by appointing Mr. Pierre Broqua and Mr. Jean Volatier, as tellers, as well as Mr. Eric Duranson, as secretary of the general meeting.
All the resolutions submitted to vote have been adopted by the shareholders, with the exception of the eleventh, as recommended by the Board of Directors.
Information on the results of the votes is detailed below:
- Total number of shares composing the share capital: : 42 134 169
- Total number of shares with voting rights: 42 027 480
| Ordinary part | Extraordinary part | |||||
Shareholders | Shares | Votes | Shareholders | Shares | Votes | ||
Shareholders present | 0 | 0 | 0 | 0 | 0 | 0 | |
Proxy to third parties | 0 | 0 | 0 | 0 | 0 | 0 | |
Proxy to the Chairman | 119 | 2 060 712 | 2 188 682 | 119 | 2 060 712 | 2 188 682 | |
Mail votes | 84 | 24 451 455 | 36 586 555 | 84 | 24 451 455 | 36 586 555 | |
TOTAL | 203 | 26 512 167 | 38 775 237 | 203 | 26 512 167 | 38 775 237 | |
Quorum | 63,082 % | 63,082 % |
VOTE RESULTS Ordinary Resolutions | |||||||||||
Resolution | Result | For | Against | Abstention | Total number of votes cast | Number of represented shares | Proportion of represented share capital | Quorum | |||
Votes | % | Votes | % | Votes | % | ||||||
1 | Adopted | 38 758 418 | 99.96 % | 15 859 | 0.04 % | 960 | - | 38 774 277 | 26 512 167 | 62.923 % | 63.082 % |
16 | Adopted | 38 755 524 | 99.95 % | 18 504 | 0.05 % | 1 209 | - | 38 774 028 | 26 512 167 | 62.923 % | 63.082 % |
VOTE RESULTS Extraordinary Resolutions | |||||||||||
Resolution | Result | For | Against | Abstention | Total number of votes cast | Number of represented shares | Proportion of represented share capital | Quorum | |||
Votes | % | Votes | % | Votes | % | ||||||
2 | Adopted | 35 614 593 | 91.85 % | 3 160 114 | 8.15 % | 530 | - | 38 774 707 | 26 512 167 | 62.923 % | 63.082 % |
3 | Adopted | 35 607 497 | 91.83 % | 3 167 160 | 8.17 % | 580 | - | 38 774 657 | 26 512 167 | 62.923 % | 63.082 % |
4 | Adopted | 35 605 052 | 91.83 % | 3 169 505 | 8.17 % | 680 | - | 38 774 557 | 26 512 167 | 62.923 % | 63.082 % |
5 | Adopted | 35 605 302 | 91.83 % | 3 169 355 | 8.17 % | 580 | - | 38 774 657 | 26 512 167 | 62.923 % | 63.082 % |
6 | Adopted | 35 605 466 | 91.83 % | 3 169 090 | 8.17 % | 681 | - | 38 774 556 | 26 512 167 | 62.923 % | 63.082 % |
7 | Adopted | 35 606 951 | 91.83 % | 3 167 646 | 8.17 % | 640 | - | 38 774 597 | 26 512 167 | 62.923 % | 63.082 % |
8 | Adopted | 35 607 577 | 91.83 % | 3 167 181 | 8.17 % | 479 | - | 38 774 758 | 26 512 167 | 62.923 % | 63.082 % |
9 | Adopted | 35 608 177 | 91.83 % | 3 166 430 | 8.17 % | 630 | - | 38 774 607 | 26 512 167 | 62.923 % | 63.082 % |
10 | Adopted | 35 608 127 | 91.83 % | 3 166 280 | 8.17 % | 830 | - | 38 774 407 | 26 512 167 | 62.923 % | 63.082 % |
11 | Rejected | 10 448 947 | 26.95 % | 28 325 160 | 73.05 % | 1 130 | - | 38 774 107 | 26 512 167 | 62.923 % | 63.082 % |
12 | Adopted | 38 751 168 | 99.94 % | 23 539 | 0.06 % | 530 | - | 38 774 707 | 26 512 167 | 62.923 % | 63.082 % |
13 | Adopted | 35 608 520 | 91.84 % | 3 164 553 | 8.16 % | 2 164 | - | 38 773 073 | 26 512 167 | 62.923 % | 63.082 % |
14 | Adopted | 35 606 496 | 91.83 % | 3 167 922 | 8.17 % | 819 | - | 38 774 418 | 26 512 167 | 62.923 % | 63.082 % |
15 | Adopted | 35 602 218 | 91.82 % | 3 171 900 | 8.18 % | 1 119 | - |
By: GlobeNewswire
- 26 Jan 2023
Return to news
Upcoming Life Sciences Events
|